BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37379070)

  • 1. Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
    Singh A; Sontag MK; Zhou M; Dasgupta M; Crume T; McLemore M; Galadanci N; Randall E; Steiner N; Brandow AM; Koch K; Field JJ; Hassell K; Snyder AB; Kanter J
    JMIR Public Health Surveill; 2023 Jun; 9():e42816. PubMed ID: 37379070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Ascertainment of Sickle Cell Disease Using Surveillance or Single Administrative Database Case Definitions.
    Reeves SL; Horiuchi S; Zhou M; Paulukonis S; Snyder A; Wilson-Frederick S; Hulihan M
    Public Health Rep; 2024; 139(2):187-194. PubMed ID: 37204194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease.
    Snyder AB; Zhou M; Theodore R; Quarmyne MO; Eckman J; Lane PA
    Public Health Rep; 2019; 134(3):274-281. PubMed ID: 30970223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying sickle cell disease cases using administrative claims.
    Reeves S; Garcia E; Kleyn M; Housey M; Stottlemyer R; Lyon-Callo S; Dombkowski KJ
    Acad Pediatr; 2014; 14(5 Suppl):S61-7. PubMed ID: 24882379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of ICD-10-CM diagnosis codes for identifying children with Sickle Cell Anemia.
    Reeves SL; Madden B; Wu M; Miller LS; Anders D; Caggana M; Cogan LW; Kleyn M; Hurden I; Freed GL; Dombkowski KJ
    Health Serv Res; 2020 Apr; 55(2):310-317. PubMed ID: 31916247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing Visibility of Sickle Cell Disease in Indiana: Establishing Baseline Prevalence Using Integrated Data From Multiple Sources.
    Okolo AI; Jacob SA; Dixon BE; Valvi NR; Janson IA; Hardesty BM
    Public Health Rep; 2024; 139(2):201-207. PubMed ID: 37232202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).
    Paulukonis ST; Harris WT; Coates TD; Neumayr L; Treadwell M; Vichinsky E; Feuchtbaum LB
    Pediatr Blood Cancer; 2014 Dec; 61(12):2271-6. PubMed ID: 25176145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administrative data identify sickle cell disease: A critical review of approaches in U.S. health services research.
    Grosse SD; Green NS; Reeves SL
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28703. PubMed ID: 32939942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD).
    Mupfudze TG; Preussler JM; Sees JA; SanCartier M; Arnold SD; Devine S
    Transplant Cell Ther; 2021 Apr; 27(4):345-351. PubMed ID: 33836889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining Adherence to Quality Indicators in Sickle Cell Anemia Using Multiple Data Sources.
    Neunert CE; Gibson RW; Lane PA; Verma-Bhatnagar P; Barry V; Zhou M; Snyder A
    Am J Prev Med; 2016 Jul; 51(1 Suppl 1):S24-30. PubMed ID: 27320461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of a Sickle Cell Disease Cohort Within Electronic Health Records.
    Michalik DE; Taylor BW; Panepinto JA
    Acad Pediatr; 2017 Apr; 17(3):283-287. PubMed ID: 27979750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Outcomes for Patients With Sickle Cell Disease in the United States: Making the Case for More Resources, Surveillance, and Longitudinal Data.
    Kanter J; Meier ER; Hankins JS; Paulukonis ST; Snyder AB
    JAMA Health Forum; 2021 Oct; 2(10):e213467. PubMed ID: 36218900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
    Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
    BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claims.
    Adler J; Jary HK; Eder SJ; Dong S; Brandt E; Haraga JK; Dombkowski KJ
    PLoS One; 2019; 14(8):e0219893. PubMed ID: 31412045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease among Latinx in California.
    Valle J; Baker JR; Madrigal D; Ferrerosa J; Paulukonis S
    PLoS One; 2022; 17(10):e0276653. PubMed ID: 36301979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Care Utilization at End of Life in Sickle Cell Disease: Highlighting the Need for a Palliative Approach.
    Johnston EE; Adesina OO; Alvarez E; Amato H; Paulukonis S; Nichols A; Chamberlain LJ; Bhatia S
    J Palliat Med; 2020 Jan; 23(1):24-32. PubMed ID: 31390292
    [No Abstract]   [Full Text] [Related]  

  • 19. A method to identify California's sickle-cell disease population and its linkage to the California Cancer Registry.
    Brown M; Brunson A; Wun T
    J Registry Manag; 2012; 39(2):53-61. PubMed ID: 23599029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.
    Baio J; Wiggins L; Christensen DL; Maenner MJ; Daniels J; Warren Z; Kurzius-Spencer M; Zahorodny W; Robinson Rosenberg C; White T; Durkin MS; Imm P; Nikolaou L; Yeargin-Allsopp M; Lee LC; Harrington R; Lopez M; Fitzgerald RT; Hewitt A; Pettygrove S; Constantino JN; Vehorn A; Shenouda J; Hall-Lande J; Van Naarden Braun K; Dowling NF
    MMWR Surveill Summ; 2018 Apr; 67(6):1-23. PubMed ID: 29701730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.